BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29560616)

  • 1. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
    Lee H; Kang KE; Chung H; Kim HC
    Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema.
    Velaga SB; Nittala MG; Alagorie AR; Marram J; Hu ZJ; Wang Z; Ciulla TA; Kapik B; Sadda SR; Ip M
    Can J Ophthalmol; 2024 Apr; 59(2):109-118. PubMed ID: 36803932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema.
    Moreno JB; Medina DB; Rosellón-Escobar MF; García-Aguirre JG
    BMC Ophthalmol; 2024 Mar; 24(1):113. PubMed ID: 38462613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema.
    von Schulthess EL; Maunz A; Chakravarthy U; Holekamp N; Pauleikhoff D; Patel K; Bachmeier I; Yu S; Cohen Y; Scherb MP; Jones IL; Gibson K; Willis JR; Glittenberg C; Singh RP; Fauser S
    Invest Ophthalmol Vis Sci; 2024 May; 65(5):26. PubMed ID: 38758639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESASO classification relevance in the diagnosis and evolution in diabetic macular edema patients after dexamethasone implant treatment.
    Moreno-Martínez A; Blanco-Marchite C; Andres-Pretel F; López-Martínez F; Donate-Tercero A; González-Aquino E; Cava-Valenciano C; Panozzo G; Copete S
    Graefes Arch Clin Exp Ophthalmol; 2024 Apr; ():. PubMed ID: 38573350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning assisted fluid volume calculation for assessing anti-vascular endothelial growth factor effect in diabetic macular edema.
    Jin Y; Yong S; Ke S; Zhang C; Liu Y; Wang J; Lu T; Sun Y; Wang H; Zhang J
    Heliyon; 2024 Apr; 10(8):e29775. PubMed ID: 38699726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripapillary pachychoroid syndrome treated with dexamethasone implant: A case report.
    Feo A; La Spina C; Romano MR; Querques G; Panico E; Panico C; Del Turco C
    Eur J Ophthalmol; 2024 May; ():11206721241254132. PubMed ID: 38751124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants.
    García-Layana A; Figueroa MS; Arias L; Adán A; Cabrera F; Abraldes M; Fernández-Vega Á; Navarro R; Cervera E; Silva R; Armadá F; Donate J; Ruiz-Moreno JM
    Ophthalmologica; 2018; 240(2):61-72. PubMed ID: 29617689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety.
    Mishra SK; Gupta A; Patyal S; Kumar S; Raji K; Singh A; Sharma V
    Int J Retina Vitreous; 2018; 4():13. PubMed ID: 29632703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes and predicting factors for diabetic macular edema treated with ranibizumab - One-year real-life results in Taiwan.
    Lai TT; Yang CM; Yang CH; Ho TC; Hsieh YT
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):194-202. PubMed ID: 29609918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review.
    Lu L; Jiang Y; Jaganathan R; Hao Y
    J Ophthalmol; 2018; 2018():1694187. PubMed ID: 29576875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion.
    Bandello F; Augustin A; Tufail A; Leaback R
    Eur J Ophthalmol; 2018 Nov; 28(6):697-705. PubMed ID: 29631435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study.
    Yoon YH; Kim JW; Lee JY; Kim IT; Kang SW; Yu HG; Koh HJ; Kim SS; Chang DJ; Simonyi S
    Ophthalmologica; 2018; 240(2):81-89. PubMed ID: 29642062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Medication Use.
    Thulliez M; Angoulvant D; Pisella PJ; Bejan-Angoulvant T
    JAMA Ophthalmol; 2018 May; 136(5):557-566. PubMed ID: 29566105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
    Glassman AR; Liu D; Jampol LM; Sun JK;
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1199-1205. PubMed ID: 29625440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION: A Randomized Clinical Trial.
    Casselholm de Salles M; Amrén U; Kvanta A; Epstein DL
    Retina; 2019 Jul; 39(7):1370-1376. PubMed ID: 29624543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACCURACY AND PRECISION OF INTRAVITREAL INJECTIONS OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN REAL LIFE: What Is Actually in the Syringe?
    Loewenstein I; Goldstein M; Moisseiev J; Moisseiev E
    Retina; 2019 Jul; 39(7):1385-1391. PubMed ID: 29659411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between myocardial infarction and intravitreal bevacizumab injection.
    Kwon JW; Jee D; La TY
    Medicine (Baltimore); 2018 Mar; 97(13):e0198. PubMed ID: 29595656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Incidence and Progression of Diabetic Retinopathy on Vision-Specific Functioning.
    Gupta P; Liang Gan AT; Kidd Man RE; Fenwick EK; Kumari N; Tan G; Mitchell P; Sabanayagam C; Wong TY; Cheng CY; Lamoureux EL
    Ophthalmology; 2018 Sep; 125(9):1401-1409. PubMed ID: 29571830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.